The Brazilian health regulatory agency, ANVISA, has been making headlines for its decision to allow imported cannabis oil from Medical Marijuana, Inc. (MJNA) as a treatment option for severe seizures. The company’s Real Scientific Hemp Oil™ has been approved for another indication as well. As of November 2015, RSHO™ oil is approved for Parkinson’s disease sufferers as well as those with epilepsy and certain chronic pain conditions including migraine headaches.
Any Brazilian resident with an approved medical indication will be allowed to import scientifically formulated cannabis oil: RSHO™. ANVISA has made documentation for approval readily available on its website. The hemp plant from which cannabis oil is derived is considered a food nutrient that does not produce the psychotropic effects of THC-laden marijuana. CBD hemp oil is available across the United States and in U.S. territories, but until recently it was not allowed in Brazil, where all cannabis-derived products – even hemp – were considered illegal.
Parkinson’s disease is a serious illness that affects an estimated 10 million sufferers worldwide. According to the Parkinson’s Disease Foundation, the disease costs nearly $25 billion to treat each year in the United States alone. The disease affects as many as one million people in the United States and approximately 60,000 Americans are diagnosed with Parkinson’s Disease per year. Many cases go undiagnosed and untreated.
Parkinson’s disease is known to worsen with age, but many people are not diagnosed until after the age of 50. Men are significantly more likely to develop the disease than women. Standard Parkinson’s disease medications cost the average patient with the disease $2,500 each year. Surgery costs can easily add up to $100,000 for every affected person. RSHO™ cannabis oil provides an affordable option for those suffering from Parkinson’s disease.
Sufferers of Parkinson’s disease experience progressive deterioration of the nervous system. Parkinson’s disease usually begins with small tremors that gradually worsen and lead to stiffness and immobility throughout the body. The neurons that produce dopamine, a neurochemical that facilitates movement and helps reduce pain and regulate mood, are generally targeted by the disease throughout its progression. The cause of Parkinson’s disease is unknown, but genetics and environmental factors are believed to have a role. The presence of the disease within a person’s immediate family significantly increases the likelihood that he will develop Parkinson’s disease as well.
Symptoms of the Disease
Some of the more distressing symptoms of Parkinson’s disease include postural instability, rigidity, tremors and slowness. The tremors can occur in the limbs as well as the hands and face. Parkinson’s sufferers also often suffer from depression, swallowing issues, psychosis, fatigue, insomnia and pain.
While there is no known cure for Parkinson’s disease, there are medications that can help control the symptoms. Cannabis oil has been shown potentially effective at slowing the progress of Parkinson’s disease and shielding the neurons from damage. Cannabinoids, such as those found in RSHO™ products, suppress excitotoxicity that causes damage to the neurons that release dopamine. They can also improve overall cellular function for better health. Researchers have found that THC also helps treat Parkinson’s disease by preventing free radical damage and encouraging new mitochondria to form.
Multiple studies have shown positive effects for Parkinson’s patients who used cannabis products. From a reduction in motor disturbances, such as tremors and rigidity, to overall improvements in quality of life, cannabis products are a promising treatment option. Despite the scientifically demonstrated effectiveness of cannabis as a treatment for Parkinson’s disease, only 4.3 percent of patients have actually used cannabis as a treatment option.
CBD may also help Parkinson’s disease patients who are experiencing psychosis. Psychosis is a stressful psychiatric state that can occur less frequently when patients have CBD oil treatment. While only nine U.S. states have included marijuana as a treatment option for Parkinson’s disease, CBD hemp oil is far more accessible.
Medical Marijuana, Inc. and RSHO™ products are at the forefront of the effort to make cannabis oil available to Parkinson’s disease patients around the world. While Brazil and the United States have made promising strides by extending availability of RSHO™ products to Parkinson’s sufferers, there are still many others who could benefit from these highly effective oils. Because RSHO™ hemp oils do not produce the euphoric state as marijuana products do, patients can experience the increased quality of life that comes with treatment without experiencing other psychotropic side effects.
About the Author
Stuart Smith is the CEO and Founder of SmallCapVoice.com. SmallCapVoice.com. is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://smallcapvoice.com/blog/the-small-cap-daily-small-cap-newsletter/